MeSH tree: C14.907.585.124
Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management. The findings were presented at the EAPCI Summit 2026, a new ...
Feb 19, 2026
0
0
A new expert opinion from the Society for Cardiovascular Angiography & Interventions (SCAI) examines the evolving role of angiography-derived physiology (ADP), a wire-free method for coronary physiologic assessment that applies ...
Feb 7, 2026
0
0
The Department of Medicine at University of Calgary led an analysis comparing several clinical mental disorders with risk of acute coronary syndrome, a term that includes heart attack and emergency chest pain resulting from ...
A major global review has revealed critical gaps in how heart attacks in women are diagnosed and treated—particularly for premenopausal women. The American Heart Association (AHA) today released a new scientific statement ...
Feb 4, 2026
0
0
Preexisting hyperlipidemia in pregnancy is associated with heightened risks of obstetric complications and early cardiovascular events in the first five years postpartum, according to a new study being presented at ACC's ...
Oct 17, 2025
0
0
Although cardiovascular disease is a leading cause of death for women, they remain underrepresented in clinical trials for common heart conditions. These findings, by investigators in the Smidt Heart Institute at Cedars-Sinai, ...
Sep 8, 2025
0
0
Dual antiplatelet therapy after cardiac bypass surgery is no more effective than acetylsalicylic acid alone and also increases the risk of serious bleeding. This is shown in a study by researchers at Karolinska Institutet ...
Sep 1, 2025
0
0
Noninferiority was not demonstrated for death and ischemic events between P2Y12 inhibitor monotherapy and dual antiplatelet therapy (DAPT) given for 12 months after stenting in patients with acute coronary syndromes (ACS), ...
Sep 1, 2025
0
0
A comprehensive analysis of nearly 29,000 patients with coronary artery disease (CAD) suggests that clopidogrel, a commonly prescribed blood thinner, is more effective than aspirin in preventing serious heart and stroke events, ...
Sep 1, 2025
0
0
In a follow-up investigation into the multibillion-dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval.
Jun 19, 2025
0
32
